Comparison between immunocytochemical and polymerase chain reaction techniques for detection of oestrogen receptor and transforming growth factor β in breast cancer

British Journal of Cancer

Volumn 73, Issue 10, 1996, Pages 1255-1259

  Amoils, K D ^a   Seymour, L ^a   Bezwoda, W R ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Immunocytochemistry; Oestrogen receptor; PCR; TGF

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0029894212     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.240     Document Type: Article

References (34)

1. BARRETT-LEE P, TRAVERS M, LUQMANI Y AND COOMBES RC. (1990). Transcripts for transforming growth factors in human breast cancer: clinical correlates. Br. J. Cancer, 61, 612-617.
2. CHOMCZYNSKI P AND SACCHI N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroforin extraction. Anal. Biochem., 162, 156-159.
3. CLARK GM, OSBORNE CK AND MCGUIRE WL. (1984). Correlations between estrogen receptor, progesterone receptor and patient characteristics in human breast cancer. J. Clin. Oncol., 2, 1102-1109.
4. COOKE T, GEORGE D, SHIELDS R, MAYNARD PV AND GRIFFITHS K. (1979). Oestrogen receptors and prognosis in early breast cancer. Lancet, 1, 995-997.
5. DAO TL AND NEMOTO T. (1980). Steroid receptors and response to endocrine ablation in women with metastatic cancer of the breast. Cancer, 46, 2779-2782.
6. DE SOMBRE ER, CARBONE PP, JENSEN EV, MCGUIRE WL, WELLS SA Jr, WITTLIFF JL AND LIPSETT MB. (1979). Steroid receptors in breast cancer. N. Engl. J. Med., 301, 1011-1012.
7. DE SOMBRE E, THORPE S, ROSE C, BLOUGH RR, ANDERSEN KW, RASMUSSEN BB AND KING WJ. (1986). Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer. Cancer Res., 46 (suppl.), 4256S-4264S.
8. FUQUA SAW, ALLRED DC, ELLEDGE RM, KRIEG SL, BENEDIX MG, NAWAZ Z, O'MALLEY BW, GREENE GL AND MCGUIRE WL. (1993). The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain. Breast Cancer Res. Treat., 26, 191-202.
9. GLAUBER JG AND KIANG DT (1992). The changing role of hormonal treatment in advanced breast cancer. Semin. Oncol., 19, 308-316.
10. GREEN S, WALTER P, KUMAR V, KRUST A, BORNERT J-M, ARGOS P AND CHAMBON P. (1986). Human oestrogen receptor cDNA: sequence, expression and homology to v-erbA. Nature, 320, 134-139.
11. HIRAYAMA D, FUJIMORI I, SATONAKA K, NAKAMURA T, KITAZAWA S, HORIO M, MAEDA S AND NAGASAKO K. (1992). Immunohistochemical study of epidermal growth factor and transforming growth factor-β in the penetrating type of early gastic cancer. Hum. Pathol., 23, 681-685.
12. JONAT W, MAASS H AND STEGNER H. (1986). Immunohistochemical measurement of estrogen receptors in breast cancer tissue samples. Cancer Res., 46, 4256S-4298S.
13. KING WL AND GREEN GL. (1984). Monoclonal antibodies localize oestrogen receptor to the nuclei of target cells. Nature, 307, 293-304.
14. KING WL, DE SOMBRE ER, JENSEN EV AND GREEN GL. (1985). Comparison of immunocytochemical and steroid binding assays for estrogen receptor in human breast tumours. Cancer Res., 45, 293-304
15. KNABBE C, LIPPMAN ME, WAKEFIELD LM, FLANDERS KC, KASID A, DERYNCK R AND DICKSON RB. (1987). Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48, 417-428.
16. KNIGHT WA, LIVINGSTON RB, GREGORY EJ AND MCGUIRE WL. (1977). Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res., 37, 4669-4671.
17. KORENMAN SG AND DUKES BA. (1970). Specific estrogen binding by the cytoplasm of breast carcinoma. J. Clin. Endocrinol., 30, 639-645.
18. LEVIN J, RAY G, DA FONSECA M, LANGE M, DE MOOR NG AND SAVAGE M. (1978). Oestrogen receptor in tumours of breast cancer patients. S. Afr. Med. J., 53, 447-479.
19. LIPPMAN ME AND ALLEGRA JC. (1980). Quantitative estrogen receptor analysis: the response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval. Cancer, 46, 2829-2834.
20. MCCARTY KS Jr, SVABO E. FLOWERS JL, COX EB, LEIGHT GS, MILLER L, KONRATH J, SOPER JT, BUDWIT DA, CREASMAN WT, SEIGLER HF AND MCCARTY KS Snr. (1986). Use of a monoclonal antiestrogen receptor antibody in the immunohistochemical evaluation of human tumours. Cancer Res., 46 (suppl.), 4244S-4248S.
21. MCGUIRE WL, PEARSON OH AND SEGALOFF A. (1975). Predicting hormone responsiveness in human breast cancer. In Estrogen Receptors in Human Breast Cancer. McGuire WL, Carbone PO and Vollmer EP (eds) pp. 27-30. Raven Press: New York.
22. MAYNARD PV, BLAMEY RW, ELSTON CW, HAYBITTLE JL AND GRIFFITHS K. (1978). Oestrogen receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res., 39, 4292-4295.
23. OSBORNE CK, YOCHMOWITZ MG, KNIGHT WAHI AND MCGUIRE WL. (1980). The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer, 46, 2884-2888.
24. PARIDAENS R, SYLVESTER RJ, FERRAZZI E, LEGROS N, LECLERQ G AND HEUSON JC. (1980). Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer. Cancer, 46, 2889-2895.
25. PEGORARO R, KARNAN V, NIRMUL D AND JOUBERT S. (1986). Estrogen and progesterone receptors among women of different racial groups. Cancer Res., 46, 2117-2120.
26. PELTON RW, DICKINSON ME, MOSES HL AND HOGAN BLM. (1990). In situ hybridization analysis of TGFβ3 RNA expression during mouse development: comparative studies with TGFβ1 and β2. Development, 110, 609-620.
27. PONGLIKITMONGKOL M, GREEN S AND CHAMBON P. (1988). Genomic organization of the human estrogen receptor gene. EMBO J., 7, 3385-3388.
28. ROBERTS AB, THOMPSON NL, HEINE U, FLANDERS C AND SPORN MB. (1988). Transforming growth factor-β: possible roles in carcinogenesis. Br. J. Cancer, 57, 594-600.
29. ROSE C, THORPE SM, ANDERSON KW, PEDERSON BV, MOURIDSEN HT, BLICHERT-TOFT M AND RASMUSSEN BB. (1985). Beneficial effect of tamoxifen in primary breast cancer patients with high estrogen receptor values. Lancet, 1, 16-18.
30. SEYMOUR L, MEYER K, ESSER J, MACPHAIL AP, BEHR A AND BEZWODA WR. (1990). Estimation of PR and ER by immunocytochemistry in breast cancer. Am. J. Clin. Pathol., 94 (suppl 1), 35-40.
31. STEFANINI M, DE MARTINO C AND ZAMBONI L, (1967). Fixation of ejaculated spermatazoa for electron microscopy. Nature, 216, 173-174.
32. THORPE SM, ROSE C, RASMASSEN BB, MOURIDSEN HT, BAYER T AND KEIDING N. (1987). Prognostic value of steroid hormone receptors and multivariate analysis of systemically untreated patients with node negative primary breast cancer. Cancer Res., 47, 6126-6133.
33. WITTLIFF JL. (1979). The steroid receptors of experimental mammary tumours and their relationship to those of human breast carcinoma. Mol. Aspects Med., 2, 395-437.
34. WITTLIFF JL. (1984). Steroid hormone receptors in breast cancer. Cancer, 53, 630-643.